Diazepam in emulsion form for intravenous usage.
Since aqueous solutions of diazepam were introduced into clinical practice, the problem has arisen of local vascular side effects after intravenous injection. A new preparation of diazepam as a lipid emulsion is presented. It was prepared by Vitrum and shows many similarities to Intralipid. A clinical trial was designed to study the incidence of pain in connection with the intravenous injection of diazepam and the incidence of subsequent thrombophlebitis. The preparation was used as a sedative to patients before gastroscopic investigation and as an inductor to general anaesthesia. In the material of 88 patients, thrombophlebitis was observed in 1.1%. Only 1 patient in the group of 314 patients studied complained of pain in connection with injection. The results observed were compared with previous investigations from the literature and with parallel control investigations. The new lipid emulsion form of the preparation was found to reduce significantly the incidence of local side effects involving the venous system. No significant difference in the therapeutic effect of the different preparative forms of the active substance was observed. The possible mechanisms involving the production of thrombophelbitis in connection with the injection of aqueous solutions of diazepam are discussed.
D000759:Adjuvants, Anesthesia / Q000008:administration & dosage* / Q000009:adverse effects; D002986:Clinical Trials as Topic; D003975:Diazepam / Q000008:administration & dosage* / Q000009:adverse effects; D004341:Drug Evaluation; D004655:Emulsions; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008055:Lipids / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D010146:Pain; D013924:Thrombophlebitis / Q000139:chemically induced
D000759:Adjuvants, Anesthesia; D004655:Emulsions; D008055:Lipids; D003975:Diazepam